August 31, 2007

Circulating nerve growth factor levels in relation to obesity and the metabolic syndrome in women

MBMònica BullóInstitut d'Investigació Sanitària Pere Virgili RPRiyad PeeraullyUniversity of Liverpool PTPaul TrayhurnUniversity of Liverpool

Key Points

Key points are not available for this paper at this time.

Abstract

NGF is upregulated in obesity, type 2 diabetes, and the MetSyn. Whether this NT may contribute to inflammation and the metabolic derangements associated with body weight gain remains to be elucidated.

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Bulló et al. (Fri,) studied this question.

synapsesocial.com/papers/69d7d5227392c8ce61bedeea https://doi.org/https://doi.org/10.1530/eje-06-0716

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Difference in Leptin mRNA Levels Between Omental and Subcutaneous Abdominal Adipose Tissue From Obese Humans1996 · 240 citations
2Epidermal and nerve growth factors manifest antilipolytic and lipogenic activities in isolated rat adipocytes1985 · 14 citations
3Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations2004 · 228 citations
4Increased frequency of NGF in sera of rheumatoid arthritis and systemic lupus erythematosus patients1993 · 46 citations
5EFFECTS OF MOUSE TUMOR TRANSPLANTATION ON THE NERVOUS SYSTEM1952 · 269 citations

Demander à l'IA

Bookmark

View Full Paper